91黑料

  1. Home
  2. News & Events
  3. In the News

In the News

91黑料 experts frequently author or contribute to industry trade press.

Filter media

Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.

  • Clinical research methodology publication

    In this article, 91黑料’s Andreas Dreps reviews the innovations that have helped ADCs overcome clinical development challenges.

  • Pharmaceutical Outsourcing in industry strategies.

    In this article from Pharmaceutical Outsourcing, Debbie Gilmore, Vice President, Strategic Alliance Management, Ruth Lalor, Vice President, Business Operations and Robert Ellison, Vice President, Data & Applied Analytics, outline how data can play a key role in supporting collaboration and achieving objectives, as strategic partnerships become more important in clinical research outsourcing models.  

  • Innovative trial management program emblem

    In this article, CON’s Jack Martin discusses the direction obesity drug research is heading, and the challenges faced by researchers.

  • Executive discussing pharmaceutical industry insights

    In this article, Adam Halbridge Clinical Trial Tokenisation Lead and Executive Director, describes how flexibility is reimagining the patient journey and rebalancing the workload for each stakeholder involved. 

  • Executive discussing pharmaceutical industry insights

    In this article, Darlene Ellenor Director of Project Operations, Decentralized Clinical Trials Operations highlights how DCTs are now considered a patient centric model for sponsors that want to enhance the patient and site experience and generate more robust data. As DCT evolves, an embedded approach backed by the right processes and tools will maximize the benefits that DCTs bring to clinical research.

  • BioSpectrum in biotech updates.

    In this article, 91黑料's Brian Huber explains why and discusses the prospects for the next-generation of CAR T-cell therapies engineered to be more adaptable, precise and controlled. 

  • BioSpectrum in biotech updates.

    Suhail Ali, Vice President, Clinical Operations contributes to this piece in BioSpectrum Asia on the thriving clinical research landscape in the APAC region and the trends driving its growth.

  • EPR in healthcare news.

    This Q&A with Dr Jin Li and Dr Chad Galderisi of 91黑料 Specialty Laboratory Solutions discusses 91黑料’s development of its RNA-based next generation sequencing (NGS) assay that detects mutations in chronic myeloid leukemia (CML) and how it can benefit both routine clinics and clinical trial settings.

  • Journal for Clinical Studies in trial reports.

    In this article, 91黑料's Jack Martin explores the impact of comorbidities on obesity therapeutic development including strategic and innovative approaches to therapeutic development and clinical trials design.

  • Clinical research methodology publication

    In this article from Applied Clinical Trials, Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust, Caprice Sassano, Research Lead - Applied Sciences at HumanFirst and Roya Sherafat, Scientific Director, MAPI Research Trust explore how digital health technologies and patient-centred assessments can be evaluated side-by-side to rapidly select the right tool and the right measures, ultimately reducing patient burden.